This section of the website is for patients who have been prescribed Cabozantinib Ipsen in the UK. Information for members of the general public can be found here.

This website has been commissioned by Ipsen UK and is intended for a UK audience.

Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in Google Play or Apple App Store. Side effects should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone 01753 627777. By reporting side effects, you can help provide more information on the safety of this medicine.

Patient Support

Renal Cell Carcinoma

Booklet for patients who have been given Cabozantinib
Booklet for patients who have been given Cabozantinib
PDF / PowerPoint Deck 15 pages

Information about your medicine

CBZ-UK-000357 | November 2024
Cabozantinib Ipsen (cabozantinib) Patient Information Leaflet
Cabozantinib Ipsen (cabozantinib) Patient Information Leaflet
Website Link

We encourage you to read this important information regarding your medicine.

CBZ-UK-000356 | November 2024
Booklet for patients who have been given Cabozantinib in combination with nivolumab
Booklet for patients who have been given Cabozantinib in combination with nivolumab
PDF / PowerPoint Deck 13 pages

Information about your medicine

CBZ-UK-000337 | November 2024

To access relevant information about Renal Cell Carcinoma, please confirm the following:

I am a UK Healthcare Professional

This section is for UK healthcare professionals only. Contains promotional information

I am a UK Healthcare Professional

Adverse events should be reported.
Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on 
01753 627777.

I am a patient

This section provides information to support patients that have been prescribed Cabozantinib Ipsen.

I am a patient

I am a member of the general public

This section is for members
of the general public.

I am a member of the general public

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in Google Play or Apple App Store. Side effects should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on 01753 627777. By reporting side effects, you can help provide more information on the safety of this medicine.